Ionis Pharmaceuticals IONS Revenue recognized that was included in deferred income at the beginning of the period
Revenue recognized that was included in deferred income at the beginning of the period at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityRevenueRecognized.
The source filing: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:25 PM EST
- Fiscal year
- FY2026
- Accession
- 0000874015-26-000115
We are often entitled to bill our customers and receive payment from our customers in advance of our obligation to provide services or transfer goods to our partners. In these instances, we include the amounts in deferred revenue in our consolidated balance sheets. During the years ended December 31, 2025 and 2024, we recognized $78.4 million and $166.1 million of revenue from amounts that were in our beginning deferred revenue balance for each respective period. For further discussion, refer to our revenue recognition policy above.
Item 15. Exhibits and Financial Statement Schedules
FAQ
- What is Ionis Pharmaceuticals's revenue recognized that was included in deferred income at the beginning of the period?
- Ionis Pharmaceuticals (IONS) reported revenue recognized that was included in deferred income at the beginning of the period of $19.6M in Q4 2025.
- How has Ionis Pharmaceuticals's revenue recognized that was included in deferred income at the beginning of the period changed year-over-year?
- Ionis Pharmaceuticals's revenue recognized that was included in deferred income at the beginning of the period decreased by 52.8% year-over-year, from $41.53M to $19.6M.
- What does revenue recognized that was included in deferred income at the beginning of the period mean?
- Reflects the portion of deferred revenue or contract liabilities that has been converted into recognized revenue during the reporting period. This occurs when performance obligations under a contract are satisfied, such as achieving clinical milestones or delivering licensed technology.
Ask your AI about Ionis Pharmaceuticals's revenue recognized that was included in deferred income at the beginning of the period.
Connect your AI assistant and compare it to peers, right in your chat.
